Carlsmed, Inc. CARL

Company Overview

Carlsmed, Inc. is a U.S.-based medical technology company focused on personalized spine surgery solutions, primarily for complex spinal deformity and degenerative spine conditions. The company operates within the orthopedic medical device and digital health sectors, combining surgical planning software, artificial intelligence-driven analytics, and patient-specific implant manufacturing. Its core offering centers on personalized spinal implants and procedural planning systems designed to improve surgical precision and patient outcomes in spine reconstruction procedures.

The company’s primary commercial platform is its patient-specific spinal surgery ecosystem, which integrates preoperative imaging, predictive analytics, and customized implant production. Carlsmed serves spine surgeons, hospital systems, and ambulatory surgical centers, with a strategic emphasis on value-based healthcare and procedural optimization. Founded in California, the company evolved from a spine-focused implant developer into a technology-enabled surgical planning business leveraging data science and additive manufacturing capabilities to differentiate itself within the competitive spine device market.

Business Operations

Carlsmed generates revenue primarily through the sale of personalized spinal implants, surgical planning services, and related procedural technologies. Its operations are centered around integrated surgical workflow solutions that combine proprietary software, imaging analysis, and manufacturing processes. The company’s core platform, commonly associated with its personalized spine surgery system, supports surgeon decision-making by using patient-specific anatomical data to design implants and optimize alignment objectives before surgery.

The company’s operations are primarily concentrated in the United States, though its technology platform and manufacturing capabilities position it for broader international expansion over time. Carlsmed maintains control over several important operational assets, including proprietary data analytics models, digital surgical planning tools, and customized implant design processes. Publicly available information identifies strategic relationships with healthcare providers, spine surgeons, and manufacturing partners involved in advanced implant production and medical imaging integration. Data regarding large-scale international joint ventures or material overseas subsidiaries remains limited based on available public sources.

Strategic Position & Investments

Carlsmed’s strategic direction focuses on expanding adoption of personalized spine surgery through data-driven procedural planning and customized implant technology. The company has emphasized growth initiatives involving artificial intelligence-assisted surgical planning, scalable digital workflows, and broader commercialization of patient-specific spinal solutions. Its positioning aligns with broader healthcare trends favoring precision medicine, outcome optimization, and procedural efficiency within orthopedic and spinal surgery markets.

The company has invested in proprietary software development, clinical data collection, and advanced manufacturing capabilities supporting customized implant production. Carlsmed has also pursued partnerships with spine surgeons and healthcare systems to strengthen clinical validation and market adoption. Available public disclosures indicate continued investment in research and development tied to predictive analytics, imaging-based planning systems, and personalized implant technologies. Information regarding major acquisitions or extensive portfolio holdings is limited in currently available public filings and company disclosures.

Geographic Footprint

Carlsmed is headquartered in Carlsbad, California, and its commercial activities are primarily concentrated in the United States spine surgery market. The company’s operational footprint includes collaboration with surgeons and healthcare providers across multiple U.S. regions, particularly within advanced orthopedic and spine care networks. Its domestic market presence reflects the significant size of the U.S. spinal implant and procedural planning sector.

Although the company’s commercial emphasis remains largely North American, its technology model and manufacturing approach have relevance for broader international expansion. Public information indicates interest in scaling personalized surgical technologies beyond the domestic market, though confirmed operational depth across Europe, Asia-Pacific, or other international regions remains limited in available disclosures. Data regarding substantial international manufacturing operations or major foreign subsidiaries is inconclusive based on available public sources.

Leadership & Governance

Carlsmed was founded by executives and medical technology professionals with experience in orthopedic devices, spine surgery, and healthcare innovation. The company’s leadership strategy has consistently emphasized personalized medicine, surgeon collaboration, and technology-enabled procedural improvement. Its governance approach reflects a focus on clinical validation, scalable commercialization, and long-term innovation within the spinal surgery market.

Key executives identified in public company materials and corporate disclosures include:

• Mike Cordonnier – Chief Executive Officer
• Andrew Bares – Chief Technology Officer
• Brent Ness – Chief Financial Officer
• Dr. Robert Eastlack – Chief Medical Officer

Leadership communications and investor-facing materials emphasize expanding access to personalized spinal surgery, integrating artificial intelligence into surgical planning, and building a scalable data-centric medical technology platform. Public disclosures also indicate a strategic focus on clinical evidence generation and partnerships with leading spine surgeons and healthcare institutions.